Pharmacodynamic Assessment of Cefprozil against Streptococcus pneumoniae: Implications for Breakpoint Determinations

Documenti analoghi

• Pharmacodynamic Assessment of Gatifloxacin against Streptococcus pneumoniae
  di: Mattoes, Holly M., et al.
  Pubblicazione: (2001)
• Pharmacodynamic Comparisons of Levofloxacin, Ciprofloxacin, and Ampicillin against Streptococcus pneumoniae in an In Vitro Model of Infection
  di: Lacy, Melinda K., et al.
  Pubblicazione: (1999)
• Pharmacodynamic Profile of Telithromycin against Macrolide- and Fluoroquinolone-Resistant Streptococcus pneumoniae in a Neutropenic Mouse Thigh Model
  di: Tessier, Pamela R., et al.
  Pubblicazione: (2005)
• Pharmacodynamic Assessment of Ertapenem (MK-0826) against Streptococcus pneumoniae in a Murine Neutropenic Thigh Infection Model
  di: Xuan, Dawei, et al.
  Pubblicazione: (2002)
• Pharmacodynamics of a Novel Des-F(6)-Quinolone, BMS-284756, against Streptococcus pneumoniae in the Thigh Infection Model
  di: Nicolau, David P., et al.
  Pubblicazione: (2003)